Cohen, Bruce M.

The mutational constraint spectrum quantified from variation in 141,456 humans

Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature

Genomics and Rare DiseasesGenetic Associations and Epidemiology

Cited by 9,434

A genomic mutational constraint map using variation in 76,156 human genomes

Chen, S., Francioli, L. C., Goodrich, J. K., Collins, R. L., Kanai, M., Wang, Q., Alföldi, J., Watts, N. A., Vittal, C., Gauthier, L. D., et al. (2024) · Nature

Genomics and Rare DiseasesGenetic Associations and Epidemiology

Cited by 1,727

A structural variation reference for medical and population genetics

Collins, R. L., Brand, H., Karczewski, K. J., Zhao, X., Alföldi, J., Francioli, L. C., Khera, A. V., Lowther, C., Gauthier, L. D., Wang, H., et al. (2020) · Nature

Genomic variations and chromosomal abnormalitiesGenomics and Rare Diseases

Cited by 1,037

Rare coding variants in ten genes confer substantial risk for schizophrenia

Singh, T., Poterba, T., Curtis, D., Akil, H., Al Eissa, M., Barchas, J. D., Bass, N., Bigdeli, T. B., Breen, G., Bromet, E. J., et al. (2022) · Nature

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 983

Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease

Schweitzer, J. S., Song, B., Herrington, T. M., Park, T.-Y., Lee, N., Ko, S., Jeon, J., Cha, Y., Kim, K., Li, Q., et al. (2020) · New England Journal of Medicine

Pluripotent Stem Cells ResearchParkinson's Disease Mechanisms and Treatments

Cited by 542

Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats

Carlezon, W. A., Béguin, C., DiNieri, J. A., Baumann, M. H., Richards, M. R., Todtenkopf, M. S., Rothman, R. B., Ma, Z., Lee, D. Y.-W., & Cohen, B. M. (2006) · The Journal of Pharmacology and Experimental Therapeutics

Neuropeptides and Animal PhysiologyTreatment of Major Depression

Cited by 390

Functional magnetic resonance imaging of facial affect recognition in children and adolescents

BAIRD, A. A., GRUBER, S. A., FEIN, D. A., MASS, L. C., STEINGARD, R. J., RENSHAW, P. F., COHEN, B. M., & YURGELUN-TODD, D. A. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry

Face Recognition and PerceptionNeural and Behavioral Psychology Studies

Cited by 229

Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole

Brennan, B. P., Hudson, J. I., Jensen, J. E., McCarthy, J., Roberts, J. L., Prescot, A. P., Cohen, B. M., Pope, H. G., Renshaw, P. F., & Öngür, D. (2010) · Neuropsychopharmacology

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 168

Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate

Lyoo, I. K., Kong, S. W., Sung, S. M., Hirashima, F., Parow, A., Hennen, J., Cohen, B. M., & Renshaw, P. F. (2003) · Psychiatry Research: Neuroimaging

Advanced MRI Techniques and ApplicationsMuscle metabolism and nutrition

Cited by 140

Blockade of Astrocytic Glutamate Uptake in the Prefrontal Cortex Induces Anhedonia

John, C. S., Smith, K. L., Van'T Veer, A., Gompf, H. S., Carlezon, W. A., Cohen, B. M., Öngür, D., & Bechtholt-Gompf, A. J. (2012) · Neuropsychopharmacology

Neuroscience and Neuropharmacology ResearchTreatment of Major Depression

Cited by 136

Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles

Sonntag, K.-C., Ryu, W.-I., Amirault, K. M., Healy, R. A., Siegel, A. J., McPhie, D. L., Forester, B., & Cohen, B. M. (2017) · Scientific Reports

Mitochondrial Function and PathologyAlzheimer's disease research and treatments

Cited by 131

Low-Field Magnetic Stimulation in Bipolar Depression Using an MRI-Based Stimulator

Rohan, M., Parow, A., Stoll, A. L., Demopulos, C., Friedman, S., Dager, S., Hennen, J., Cohen, B. M., & Renshaw, P. F. (2004) · American Journal of Psychiatry

Transcranial Magnetic Stimulation StudiesBipolar Disorder and Treatment

Cited by 125

Differential brain network activity across mood states in bipolar disorder

Brady Jr., R. O., Tandon, N., Masters, G. A., Margolis, A., Cohen, B. M., Keshavan, M., & Öngür, D. (2017) · Journal of Affective Disorders

Functional Brain Connectivity StudiesBipolar Disorder and Treatment

Cited by 115

Treatment to Enhance Cognition in Bipolar Disorder (TREC-BD): Efficacy of a Randomized Controlled Trial of Cognitive Remediation Versus Active Control

Lewandowski, K. E., Sperry, S. H., Cohen, B. M., Norris, L. A., Fitzmaurice, G. M., Ongur, D., & Keshavan, M. S. (2017) · The Journal of Clinical Psychiatry

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 115

Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat

Meloni, E. G., Gerety, L. P., Knoll, A. T., Cohen, B. M., & Carlezon, W. A. (2006) · The Journal of Neuroscience

Neuropeptides and Animal PhysiologyStress Responses and Cortisol

Cited by 109

Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats

Nemeth, C. L., Paine, T. A., Rittiner, J. E., Béguin, C., Carroll, F. I., Roth, B. L., Cohen, B. M., & Carlezon, W. A. (2010) · Psychopharmacology

Neurotransmitter Receptor Influence on BehaviorPsychedelics and Drug Studies

Cited by 104

Rapid Mood-Elevating Effects of Low Field Magnetic Stimulation in Depression

Rohan, M. L., Yamamoto, R. T., Ravichandran, C. T., Cayetano, K. R., Morales, O. G., Olson, D. P., Vitaliano, G., Paul, S. M., & Cohen, B. M. (2014) · Biological Psychiatry

Transcranial Magnetic Stimulation StudiesElectroconvulsive Therapy Studies

Cited by 97

Brain Kinetics of Paroxetine and Fluoxetine on the Third Day of Placebo Substitution: A Fluorine MRS Study

Henry, M. E., Moore, C. M., Kaufman, M. J., Michelson, D., Schmidt, M. E., Stoddard, E., Vuckevic, A. J., Berreira, P. J., Cohen, B. M., & Renshaw, P. F. (2000) · American Journal of Psychiatry

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 61

The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia

Nehme, R., Pietiläinen, O., Artomov, M., Tegtmeyer, M., Valakh, V., Lehtonen, L., Bell, C., Singh, T., Trehan, A., Sherwood, J., et al. (2022) · Nature Communications

Genomic variations and chromosomal abnormalitiesSchizophrenia research and treatment

Cited by 58

Role of the Bed Nucleus of the Stria Terminalis (BST) in the Expression of Conditioned Fear

MELONI, E. G., JACKSON, A., GERETY, L. P., COHEN, B. M., & CARLEZON, W. A. (2006) · Annals of the New York Academy of Sciences

Memory and Neural MechanismsNeuroscience and Neuropharmacology Research

Cited by 41

S-adenosyl-L-methionine: Effects on brain bioenergetic status and transverse relaxation time in healthy subjects

Silveri, M. M., Parow, A. M., Villafuerte, R. A., Damico, K. E., Goren, J., Stoll, A. L., Cohen, B. M., & Renshaw, P. F. (2003) · Biological Psychiatry

Treatment of Major DepressionAdvanced MRI Techniques and Applications

Cited by 35

Using Smartphone Apps to Promote Psychiatric Rehabilitation in a Peer-Led Community Support Program: Pilot Study

Mueller, N. E., Panch, T., Macias, C., Cohen, B. M., Ongur, D., & Baker, J. T. (2018) · JMIR Mental Health

Mental Health and Patient InvolvementDigital Mental Health Interventions

Cited by 26

Erratum: Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons

Yoshimizu, T., Pan, J. Q., Mungenast, A. E., Madison, J. M., Su, S., Ketterman, J., Ongur, D., McPhie, D., Cohen, B., Perlis, R., et al. (2015) · Molecular Psychiatry

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 21